Liver cirrhosis can develop as a consequence of chronic hepatitis, a fatty liver or alcohol abuse. Liver cells are destroyed and replaced by connective tissue.
Detailed description
Symptoms of liver cirrhosis may include dysfunctions of blood clotting and of the detoxification function as well as yellowing of the skin, weight loss and itching. The regeneration of tissue can lead to liver cancer.
Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as
Hepcludex (bulevirtide) is the first medication for the treatment of hepatitis D, a virus blocker whose development had been masterminded by DZIF Professor Dr Stephan Urban of Heidelberg University
Professor Stephan Urban and his team developed the first drug for hepatitis D at the Heidelberg University Hospital. So far, there has been no curative treatment – the number of chronically infected
Researchers at Helmholtz Zentrum München, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis
